<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medical Genetics</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1E9C8D50-3C20-4BF0-9051-FE4C73B56835"><gtr:id>1E9C8D50-3C20-4BF0-9051-FE4C73B56835</gtr:id><gtr:firstName>J</gtr:firstName><gtr:surname>Todd</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/08E61C16-156F-44D4-835F-671DEF74E432"><gtr:id>08E61C16-156F-44D4-835F-671DEF74E432</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Burton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0900756"><gtr:id>E9D2B738-8CFA-4FB1-B74D-7F01B15749B0</gtr:id><gtr:title>The Eastern Sequence and Informatics Hub (EASIH)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900756</gtr:grantReference><gtr:abstractText>The development of even faster and less expensive ways of decoding genetic material and information, so called high throughput sequencing (HTS). HTS is transforming our understanding of how organisms work, from bacteria to humans, and how certain diseases are strongly inherited. Only a few years ago, an international consortium was able to produce a first draft of the human genome sequence after many years of effort, but now it will be possible for the proposed sequencing facility in Cambridge, the Eastern Sequence and Informatics Hub (EASIH), to resequence 100 human genomes in a year. EASIH is a consortium of collaborators from three leading academic research institutions in the Cambridge region: the University of Cambridge, the European Bioinformatics Institute and the Babraham Institute, working together with the National Institute for Health Research Cambridge Comprehensive Biomedical Research Centre. The main HTS facility of EASIH will be housed in the Department of Medical Genetics in the newly-opened Addenbrooke?s Treatment Centre in the centre of the Cambridge Biomedical Campus. These four organisations have put together over #4.6M worth of funding and resources towards establishment and operation of EASIH, underpinning a bid to the MRC for a further #2.6M. We will be providing sequencing services to over 100 researchers in 16 different institutions within the Eastern region and beyond, within the context of a sustainable business plan. Our technologies and approaches, in collaboration with several biotechnology companies, in particular, Applied Biosystems and Roche-454, will help the NHS in tissue typing, which is an essential part of transplantation of stem cells, and in NHS clinical genetics services in the diagnosis of inherited diseases such as breast cancer. EASIH will be collaborating with the NHS National Blood Service (Colindale, London), the NHS Blood and Transplant Centre (Cambridge), and the NHS East Anglian Medical Genetics Service and Tissue Typing Laboratory in Cambridge to achieve these aims that will hopefully bring benefits directly to patients in the future. We will co-ordinate with the other MRC sequencing Hubs across the UK to work together on matters of national and international importance in the life sciences and in the diagnosis and treatment of disease, as well as seeking further economies of scale and synergies in this rapidly moving field.</gtr:abstractText><gtr:technicalSummary>The Eastern Sequence and Informatics Hub (EASIH) will deliver the key elements required of a world-leading high-throughput sequencing (HTS) facility: 

a) Substantial commitment of resources from leading academic institutes. The University of Cambridge, European Bioinformatics Institute (EBI), Babraham Institute-Centre for Trophoblastic Research and NIHR Cambridge Biomedical Research Centre will work together and commit over #4.6M of resources to the Hub?s establishment. 

b) State-of-the-art technology acquired at highly competitive cost, in the context of major collaborative research and early access agreements with Roche-454 and Applied Biosystems. 

c) High-level bioinformatic, statistical and data storage capacity and expertise: EBI is a principle partner; we have close relations with the Wellcome Trust Sanger Institute, BBSRC Genome Analysis Centre, MRC Biostatistics Unit, and CRUK Cancer Research Institute.

d) A substantial body of users and collaborators engaged in internationally-leading research: over 100 PIs from 16 institutes/units funded by the MRC, several Universities, BBSRC, Wellcome Trust, CRUK and NHS.

e) A physical location that fosters close and frequent interactions between users with the core laboratory and bioinformatic staff, including training facilities. EASIH is founded on eight instruments producing at least 3,600 Gbases/yr, embedded in existing core genomics facilities for validation and follow up studies. 

f) An operational and scientific management structure (Management Committee and Scientific Advisory Board) that ensures prioritisation of projects on the basis of scientific excellence and the rapid, cost-effective delivery of high quality data and analyses, and regular Users Group meetings to present results and discuss developments.

g) A business model that ensures long-term sustainability. Our five-year business plan allows for growth, replacement and progression to third generation HTS. We have allocated currently available space on-site for EASIH expansion, as we anticipate that not all Hub applications will be funded and users will have to be re-aligned to the successful bids.

h) A research development and strategic aim to apply HTS to NHS Clinical Genetics, in particular in HLA typing in transplantation and cord blood stem cells, prenatal diagnosis, and resequencing of disease genes (e.g. BRCA genes) in collaboration with the National Blood Service and Regional Clinical Genetics Services. Our facility will adhere to GLP/ISO requirements.

i) We propose formation of a Consortium of Hubs. Such a Consortium would facilitate scientific and technical cooperation between Hubs, encourage economies of scale (including software and data storage), and catalyse the tackling of major scientific questions requiring the power of a nationally co-ordinated network.</gtr:technicalSummary><gtr:fund><gtr:end>2012-11-26</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-27</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2407559</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge High Performance Computing Facility (HPCF)</gtr:department><gtr:description>Cambridge High Performance Computer Facility</gtr:description><gtr:id>370CD348-F0EE-4CB3-AFE7-AEDCA7CB5F5D</gtr:id><gtr:impact>Much of EASIH's data analysis is now performed on the cluster and the input made by EASIH staff have enabled the cluster adminstrators to develop systems in such a way that other biological researchers can use the system. The requirements for biological data analysis are quite different to the physics/astronomy type work previously done.</gtr:impact><gtr:partnerContribution>Assisting in established an environment to run biological data analysis on the University HPC</gtr:partnerContribution><gtr:piContribution>We have the expert speciallist knowledge and experience of setting up and running the software.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Ion Torrent discussion</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>C238A3BE-36C6-40C8-AA12-480C11C743AA</gtr:id><gtr:impact>Video describing Ion Torrent sequencing and its potential uses in EASIH

www.youtube.com/watch?v=mGKF_BlKlRI

Enquiries to EASIH about Ion Torrent sequencing</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=mGKF_BlKlRI</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical Genetics Society Spring Conference ASR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>2493FC20-81E0-49DF-9424-94302FE24DC7</gtr:id><gtr:impact>Promoted the NGS work and clinical application being carried out at EASIH

Raised awareness of EASIH and the clinical application being developed</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NGS in Clolrectal Cancer screening - Addenbrooke's HM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>20865239-57D7-498A-8BD8-27491B97EF12</gtr:id><gtr:impact>Application of NGS in clinical diagnosis

Raise awareness of the application of NGS in clinical diagnosis</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New and devloping technologies for genetics diagnosis</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>46F160F2-9F8A-407D-B4F8-CFEEC401B7E4</gtr:id><gtr:impact>Presentation of X exome project and discussion of EASIH as a provider for a clinical service

Generated new business</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical re-sequencing seminar series - HM Rotterdam</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>300B0016-9772-4DE1-BB58-48AB5BB78960</gtr:id><gtr:impact>To disseminate new sequence analysis developments from EASIH and promote the EASIH Clinical service

awareness of the clinical service being developed at EASIh was raised</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOLiD NGS clinical meeting HM Utrecht, NL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>66FEF4FB-01A8-434D-98A5-D530DE5189ED</gtr:id><gtr:impact>To gain and disseminate understanding of current methods available for NGS and EASIH Clinical service

Rose awareness of NGS Clinical service at EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CMGS Durham HM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9CFB2F89-20BA-45DC-A571-10BDE73E9A70</gtr:id><gtr:impact>To present developments in NGS occurring in EASIH and promote EASIH clinical service

Raised awareness of EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Developing a diagnostic NGS pipeline - HM Warwick</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7492FC4A-9085-43CD-8F54-1F367777E0AB</gtr:id><gtr:impact>Promotion of use of bioinformatics at EASIH as part of an NGS Pipeline

Raised the awareness of bioinformatics within a clinical environment</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Wellcome Trust Centre for Stem Cell research ASR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>FB1A5CB0-F37D-4E5B-86C3-1C7C2B8BD53C</gtr:id><gtr:impact>Promoted the NGS work being carried out at EASIH

Raised awareness of EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Enabling Technologies for Stem Cell and Regenerative Medicince Research IS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B1A8CC7A-91DF-49F1-8505-3CDD3FEFDD8F</gtr:id><gtr:impact>Promoted the NGS work being carried out at EASIH

Raised awareness of EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Next Gen Sequencing Presentation Tissue Typing HM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>912247B4-BD55-4A68-B197-B8B15470F499</gtr:id><gtr:impact>The staff of the Tissue Typing department listened to a presentation on current advances in NGS and EASIH - led to a discussion about NGS and HLA Typing for furture use as a clinical service

Initiated devlopment of a clinical NGS service</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NGS presentation Molecular and Cyto Genetics HM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>CE888930-347D-4CEA-8766-462FB75EF3E8</gtr:id><gtr:impact>Dissemination of current advances in NGS in relation to Molecular Genetics and Cytogenetics. Advertised EASIH

Led to enquiries from both molecular and cytogenetics</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Deepseq NGS meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4FD225AC-E117-420E-87D6-ECF7EE9F2A4F</gtr:id><gtr:impact>100 people attended a Next-gen sequencing meeting and discussed state of the art applications of the tech.

unkonwn</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NGS CLinical service development updates - Clinical Genetics HM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D0EB7439-2EA9-426F-92D9-C327FFF1E910</gtr:id><gtr:impact>Describe the proposed clinical service at EASIH

Raised awareness of the Clinical Service</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Biomedical Research Centre review Committee ASR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B17C71D2-3E19-4CBE-99C1-343EFF4B0516</gtr:id><gtr:impact>Promoted the NGS work being carried out at EASIH in preparation for funding bid

Achieved further funding for EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Biomedical Campus Open PR Event ASR</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>EDC3CAF6-AFC8-4EFE-82E1-9A8850C7FC60</gtr:id><gtr:impact>Promoted the NGS work being carried out at EASIH

Raised awareness of EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Illumina Users meeting HM Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>222D5B62-162F-4DFD-8156-7F1972BE9C37</gtr:id><gtr:impact>Describe the Ion Torrent PGM and promote use of it at EASIH in a clinical context

Awareness of PGM at EASIH was raised and its application for clinical purposes</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Re-sequencing seminar service HM Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8AA5E8EA-8B24-4706-BFA4-2F3B58DE0981</gtr:id><gtr:impact>To disseminate new sequence analysis developments from EASIH and promote the clinical service

awareness of the clinical service being developed at EASIh was raised</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EBI NGS Workshop ASR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1C7638DD-BF1D-4012-99D0-5E96CD7DA788</gtr:id><gtr:impact>Promoted the Clinical NGS/Bioinformatics work being carried out at EASIH

Raised awareness</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NGS Development Update Clinical Genetics HM</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>FBD0FDD2-E0C5-4FB5-9B43-25C1EB72F5E7</gtr:id><gtr:impact>disseminate new developments in NGS clinical projects. Advertising EASIH to Clinical Genetics

Development of Clinical Service prgressed</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge BRC Lecture Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9A7AA53D-31BF-4C3B-9E2F-A95041902467</gtr:id><gtr:impact>Promoted the NGS work being carried out at EASIH

Raised awareness of EASIH</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Cambridge Biomedical Research Centre</gtr:department><gtr:description>National Institute for Health Research (NIHR) - Cambridge Biomedical Research</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>DA073A5C-4585-4B06-A850-EB745EC97C73</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Software to post-process SOLiD data where alignment of erroneous reads causes abherrant SNP calls.</gtr:description><gtr:id>DB4A1791-F803-4705-BC24-58A5FFD556B1</gtr:id><gtr:impact>Vastly improved quality of data from SOLiD exome sequencing</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Scrubber</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>MARIS (Data Analysis technique)
We have developed an automated pipeline for the mapping of next generation sequence data to a reference genome and the accurate determination of variants based on that information. The pipeline makes use of state-of-the-art software developed in world leading genome centres (WTSI and Broad Inst) to do sophisticated analysis of sequence data. While the individual software components are freely available to anyone, tying them together in to an easy to use reproducible package that can take advantage of the University compute resources is not. This software will underpin much of the re-sequencing work that the EASIH undertakes and its upfront development will significantly reduce the analysis cost of many future projects.</gtr:description><gtr:id>C803B0C0-3C4A-4FB0-8FA8-28BDADF0CF69</gtr:id><gtr:impact>The software has been used extensively as part of a clinical translation investigation in to the application of next generation sequencing as a diagnostic tool. It has also been used to find mutations is several other whole exome re-sequencing projects including one where a clinical diagnostic group brought their sequence data to the EASIH specifically to use the software.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MARIS</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Software tool to enable non-bioinformaticians to interogate vcf file output of exome sequencing analysis.</gtr:description><gtr:id>8EC833DC-6D9A-4A25-8717-3DAA970F9CBE</gtr:id><gtr:impact>Clinical researchers are able to independantly examine their data.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>VCFView</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>EASIH (Improvement to research infrastructure)
The major aim of the EASIH project is to improve research infrastructure. Prior to the establishment of the EASIH at Cambridge the University owned only one next generation sequencing machine, a Roche 454, which is not now considered &amp;quot;high-throughput&amp;quot;. A similar scenario exists in many institutions around the country. The sequencing capacity provided by the EASIH opens up new areas of research to scientists who can not afford to buy machines or don't have the expertise to run them and analyse the data. The EASIH provides access to significant sequencing resources and experienced scientists who can understand the scientific basis of a research project and guide its design.</gtr:description><gtr:id>AF316D5A-554D-466A-85C3-4D88B12DACEA</gtr:id><gtr:impact>Having the EASIH on-site has given clinical researchers access to technology and expertise which has been invaluable in defining project and applying for funding. EASIH staff have already been included as co-applicants on several grant applications both within Cambridge University and externally.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EASIH</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3619734F-2EB1-4918-9F66-7A177C7B1D1E"><gtr:id>3619734F-2EB1-4918-9F66-7A177C7B1D1E</gtr:id><gtr:title>A mutation in the thyroid hormone receptor alpha gene.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f179cb1cb82cbedde7396a55057f866f"><gtr:id>f179cb1cb82cbedde7396a55057f866f</gtr:id><gtr:otherNames>Bochukova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B84FFAA3-2DD4-4A9C-B563-0BD5B0F818FF"><gtr:id>B84FFAA3-2DD4-4A9C-B563-0BD5B0F818FF</gtr:id><gtr:title>Distinct epigenomic features in end-stage failing human hearts.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac0eb178516883c270addb55fd4c7f8c"><gtr:id>ac0eb178516883c270addb55fd4c7f8c</gtr:id><gtr:otherNames>Movassagh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30F500D3-21D7-4C7D-8B9C-FB4C860AA9DD"><gtr:id>30F500D3-21D7-4C7D-8B9C-FB4C860AA9DD</gtr:id><gtr:title>Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/afe935ed2ec68ab227617ddae225d59b"><gtr:id>afe935ed2ec68ab227617ddae225d59b</gtr:id><gtr:otherNames>Pohler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E4EAF49-71D8-41EB-9E82-999AAC3157DD"><gtr:id>8E4EAF49-71D8-41EB-9E82-999AAC3157DD</gtr:id><gtr:title>Widespread transcription in an amphibian oocyte relates to its reprogramming activity on transplanted somatic nuclei.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c47ae7bd327b69471dbc4a455119a6f"><gtr:id>0c47ae7bd327b69471dbc4a455119a6f</gtr:id><gtr:otherNames>Simeoni I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900756</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>